Everything you need to know about ADA 2025
Check out Breakthrough T1D's ADA 2025 coverage of cutting-edge T1D updates in cures, improving lives, and clinical adoption.
Can continuous glucose monitors benefit people without type 1 diabetes?
Continuous glucose monitors have been transformative for daily type 1 diabetes management. Can they benefit people without diabetes?
ADA 2025 Recap: Medical Affairs
Medical Affairs Breakthrough T1D’s Medical Affairs program is bridging the gap between access to and adoption of therapies, treatments, drugs,…
ADA 2025 Recap: Cures
Breakthrough T1D was in Chicago, IL for ADA 2025. Here we report on the latest advancements in cures for type…
ADA 2025 Recap: Improving Lives
Improving Lives Breakthrough T1D’s Improving Lives program focuses on devices, insulins, adjunctive therapies, treatments for complications, and psychosocial interventions to…
Golf champion’s story highlights importance of screening for type 1 diabetes in adults
J.J. Spaun’s diagnosis story highlights the importance of screening and monitoring for type 1 diabetes in people of all ages.
Breakthrough T1D heads to ADA’s 85th Scientific Sessions
Breakthrough T1D is heading to Chicago, IL to attend the 2025 ADA conference from June 20-23 to discuss cutting-edge type…
Accelerating cures: Four new grants from the Breakthrough T1D x Stem Cell Network Partnership
Breakthrough T1D, Breakthrough T1D Canada, and the Stem Cell Network (SCN) have partnered to support cell therapy research in Canada.
Making cures a reality: Clinical adoption of cell therapies
The Medical Affairs team is working to ensure the clinical adoption of forthcoming manufactured cell therapies.
Breakthrough T1D and Partners Thank NIH Director For Commitment to Continuing Research in FY25
Breakthrough T1D and other research and patient advocacy organizations recently had the opportunity to meet with National Institute of Health…
